small-m edium v essel v asculitides: is the c omplement s ystem a Potential f orgotten t arget?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides

  2013cited by this paper
• Granulomatosis and polyangiitis: the rituximab option.

  2013cited by this paper
• Complement and autoimmunity

  2013cited by this paper
• Update on the classification of vasculitis.

  2013cited by this paper
• The beneficial effects of intravenous immunoglobulin for antineutrophil cytoplasmic antibody-positive vasculitis.

  2012cited by this paper
• Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy.

  2011cited by this paper
• Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy.

  2011cited by this paper
• Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

  2010cited by this paper
• Replacement therapy with C1 esterase inhibitors for hereditary angioedema.

  2010cited by this paper
• Pathophysiology of ANCA-Associated Small Vessel Vasculitis

  2010cited by this paper
• T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?

  2010cited by this paper
• C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.

  2009cited by this paper
• Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation1

  2009cited by this paper
• Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge.

  2009cited by this paper
• Hypocomplementemic urticarial vasculitis syndrome

  2009cited by this paper
• Hepatitis C Virus Infection Induced Vasculitis

  2008cited by this paper
• Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.

  2008cited by this paper
• EULAR recommendations for the management of primary small and medium vessel vasculitis

  2008cited by this paper
• Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

  2008cited by this paper
• Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.

  2007cited by this paper
• Anti-Clq antibodies in patients with chronic hepatitis C infection.

  2006cited by this paper
• Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener's granulomatosis

  2006cited by this paper
• Cryopyrin activates the inflammasome in response to toxins and ATP

  2006cited by this paper
• A review of current knowledge of the complement system and the therapeutic opportunities in inflammatory arthritis.

  2006cited by this paper
• Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

  2005cited by this paper
• Complement therapeutics; history and current progress.

  2003cited by this paper
• The complement system as a therapeutic target in autoimmunity.

  2003cited by this paper
• Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.

  2003cited by this paper
• The role of complement in B cell activation and tolerance.

  2000cited by this paper
• Predominance of IgGl and IgG4 subclasses of anti‐neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders

  1991cited by this paper
• Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

  1989cited by this paper
• Serum complement pattern in essential mixed cryoglobulinaemia.

  1978cited by this paper

• No citing papers are available for this paper.